- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Tivozanib is an oral inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase, mainly used for the treatment of advance...
Tivozanib is an oral inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase, mainly used for the treatment of advance...
Selumetinib is a MEK1/2 inhibitor targeted drug mainly used to treat type 1 neurofibromatosis (NF1) - related plexiform neurofibromatosis. It i...
Selumetinib is a MEK1/2 inhibitor targeted drug primarily used to treat type 1 neurofibromatosis (NF1) - related plexiform neurofibromatosis. I...
Dicomit is an antiepileptic drug mainly used to treat seizures in patients with Dravet syndrome (severe myoclonic epilepsy), usually used as an...
Dicomit is an antiepileptic drug used to treat Dravet syndrome, mainly exerting therapeutic effects by regulating GABAergic neurotransmission. ...
Dicomit is an antiepileptic drug mainly used to treat Dravet syndrome. It exerts therapeutic effects by regulating GABAergic neurotransmission ...
Dicomit is an antiepileptic drug mainly used to treat Dravet syndrome and refractory epilepsy. It exerts therapeutic effects by regulating GABA...
Lenvatinib is a multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as thyroid cancer, hepatocellular carcinoma, ...
Lenvatinib is a multi-target tyrosine kinase inhibitor mainly used for the treatment of malignant tumors such as thyroid cancer, hepatocellular...
